Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hemorrhage Stroke Decision Making Model Based Deep Learning (BrainHemoAI System)
Sponsor: Second Affiliated Hospital of Nanchang University
Summary
Although hemorrhagic stroke also has the characteristics of high mortality and disability rates, and constitutes a major public health problem worldwide, there is a relative lack of in-depth research teams for hemorrhagic stroke in China. The current preoperative imaging evaluation of spontaneous cerebral hemorrhage is still limited to the traditional Tada formula, and there are subjective differences in diagnosis among different doctors, making it difficult to achieve homogenization in clinical decision-making. Hemorrhagic stroke is a common and frequently occurring disease in Jiangxi Province. Therefore, establishing a new diagnosis and treatment system focused on hemorrhagic stroke can not only fill the research gap in this field in China, improve the accuracy and homogeneity of hemorrhagic stroke diagnosis and treatment, but also promote related research progress to reduce the mortality and disability rates of this disease and improve the clinical prognosis of patients.
Official title: Construction of an Integrated Intelligent Model for Spontaneous Intracerebral Hemorrhage Based on Deep Learning
Key Details
Gender
All
Age Range
8 Years - Any
Study Type
OBSERVATIONAL
Enrollment
7100
Start Date
2022-09-01
Completion Date
2026-12-30
Last Updated
2026-05-06
Healthy Volunteers
Yes
Conditions
Interventions
Large language model
Automatical diagnosis, treatment decision-making, and risk prediction after spontaneous intracerebral hemorrhage via a trained deep learning larger language model.
Locations (1)
The Second Affiliated Hospital of Nanchang University
Nanchang, China